Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06895603 · ClinicalTrials.gov registry record
The HIgh-fidelity Hydraulic couPling Upper-arm Cuff Assessment of Limits, Safety, and Effectiveness (HIPULSE) Trial (Cardiac Output Study)
A clinical trial of ICU and Pulmonary Artery Catheter (PAC), sponsored by Philips Clinical & Medical Affairs Global.
- Recruiting
- Registry status
- 75
- Enrollment target
- 2
- Study locations
NCT06895603: Recruiting study of ICU and Pulmonary Artery Catheter (PAC), sponsored by Philips Clinical & Medical Affairs Global.
NCT06895603 is a study of ICU and Pulmonary Artery Catheter (PAC) that is actively recruiting participants, run by Philips Clinical & Medical Affairs Global. The registered enrollment target is 75 participants, below the 207-participant average among 3 other ICU trials with a reported enrollment target (64% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06895603, a study of ICU and Pulmonary Artery Catheter (PAC), is actively recruiting participants, sponsored by Philips Clinical & Medical Affairs Global.
- RECRUITING
- Registry status
- 75 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to compare cardiac output (CO), fluid responsiveness, and related measurements between the Philips AMC and PAC (Swan-Ganz) in ICU or surgical patients.
Primary Outcome
The comparison of cardiac output between the Philips AMC and PAC
Conditions Studied
Interventions
- DEVICE Philips Advanced Monitoring Cuff (AMC)
Study Locations (2)
Virginia
- UVA Health - Charlottesville
Hamburg
- Universitätsklinikum Hamburg Eppendorf - Hamburg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2025-10-28 |
| Est. Completion | 2026-06 |
What NCT06895603 shows while recruiting
NCT06895603 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 207-participant average among 3 other ICU trials with a reported enrollment target (64% lower).
The record links to 3 conditions, with ICU appearing as the primary indexed condition, and to 1 intervention - of which Philips Advanced Monitoring Cuff (AMC) is the first listed.
NCT06895603 reports a single indexed study location in Virginia, Hamburg.
Frequently Asked Questions
What is clinical trial NCT06895603 about?
NCT06895603 is a clinical study titled "The HIgh-fidelity Hydraulic couPling Upper-arm Cuff Assessment of Limits, Safety, and Effectiveness (HIPULSE) Trial (Cardiac Output Study)". The purpose of this study is to compare cardiac output (CO), fluid responsiveness, and related measurements between the Philips AMC and PAC (Swan-Ganz) in ICU or surgical patients.
What is the current status of trial NCT06895603?
This trial is currently recruiting. The enrollment target is 75 participants. The study started on 2025-10-28. Estimated completion is 2026-06.
What conditions does trial NCT06895603 study?
This clinical trial studies the following conditions: ICU, Pulmonary Artery Catheter (PAC), Swan-Ganz Catheter.
What interventions are being tested in trial NCT06895603?
The interventions under investigation include: Philips Advanced Monitoring Cuff (AMC) (DEVICE).
Who is sponsoring clinical trial NCT06895603?
This trial is sponsored by Philips Clinical & Medical Affairs Global, which has 45 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06895603 being conducted?
This trial has 2 study locations across Virginia, Hamburg. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for ICU
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Returning to Everyday Tasks Utilizing Rehabilitation Networks-III (RETURN-III)
RECRUITING · NA
-
Designing a Virtual Reality Intervention to Improve Physical and Psychological Health in Intensive Care Units
ACTIVE NOT RECRUITING · NA
-
Illuminating Neuropsychological Dysfunction and Systemic Inflammatory Mechanisms Gleaned After Hospitalization in Trauma-ICU Study
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI